bf/NASDAQ:ATXS_icon.jpeg

NASDAQ:ATXS

Astria Therapeutics

  • Stock

USD

Last Close

11.77

08/11 21:00

Market Cap

572.19M

Beta: 0.92

Volume Today

136.51K

Avg: 227.03K

PE Ratio

−7.69

PFCF: −15.76

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-18.12M
-
-21.88M
20.79%
-32.63M
49.10%
-36.06M
10.51%
-27.36M
24.12%
-25.87M
5.46%
-26.29M
1.64%
-37.30M
41.86%
-194.91M
422.55%
-51.83M
73.41%
-72.89M
40.62%
depreciation and amortization
320K
-
248K
22.50%
202K
18.55%
395K
95.54%
304K
23.04%
119K
60.86%
26K
78.15%
deferred income tax
-343K
-
96K
-
-4K
104.17%
-303K
7,475%
23K
107.59%
stock based compensation
343K
-
897K
161.52%
1.66M
84.84%
2.16M
30.28%
2.01M
7.08%
1.77M
11.76%
1.51M
14.62%
1.39M
8.07%
3.36M
141.87%
4.55M
35.46%
6.31M
38.65%
change in working capital
1.09M
-
253K
76.77%
684K
170.36%
274K
59.94%
-1.93M
805.84%
762K
139.40%
-1.87M
345.41%
3.37M
280.05%
-3.31M
198.16%
2.65M
180.09%
-2.41M
191.16%
accounts receivables
inventory
accounts payables
-129K
-
481K
472.87%
196K
59.25%
77K
60.71%
-632K
920.78%
662K
204.75%
-211K
131.87%
347K
264.45%
-1.97M
666.28%
-766K
61.02%
725K
194.65%
other working capital
1.22M
-
-228K
118.72%
488K
314.04%
197K
59.63%
-1.30M
760.91%
100K
107.68%
-1.66M
1,759%
3.02M
282.04%
-1.34M
144.37%
3.41M
354.70%
-3.14M
191.94%
other non cash items
343K
-
74K
78.43%
293K
295.95%
277K
5.46%
155K
44.04%
56K
63.87%
33K
41.07%
58K
75.76%
164.70M
283,872.41%
1.10M
99.33%
545K
50.45%
net cash provided by operating activities
-16.37M
-
-20.41M
24.72%
-29.79M
45.96%
-32.86M
10.29%
-26.84M
18.33%
-23.46M
12.56%
-26.57M
13.23%
-32.48M
22.27%
-30.15M
7.18%
-43.53M
44.38%
-68.44M
57.23%
investments in property plant and equipment
-43K
-
-228K
430.23%
-421K
84.65%
-459K
9.03%
-57K
87.58%
18K
131.58%
-12K
166.67%
-33K
175%
-21K
36.36%
-91K
333.33%
-25K
72.53%
acquisitions net
45.54M
-
-18K
100.04%
4.07K
122.61%
-6.33K
255.60%
6.47M
102,200.11%
167.04K
97.42%
purchases of investments
-4.98M
-
-45.54M
-
-45.54M
0%
-70.36M
54.51%
-155.20M
120.56%
-62.78M
59.55%
-78M
24.25%
-396.06M
407.77%
-1.92B
385.89%
sales maturities of investments
4.98M
-
30.46M
-
14.91M
51.04%
48.09M
222.54%
151.13M
214.26%
69.11M
54.27%
59M
14.63%
229.03M
288.18%
2.06B
799.24%
other investing activites
52K
-
30K
42.31%
369K
1,130%
-4.07K
101.10%
6.33K
255.60%
-167.04K
-
net cash used for investing activites
-43K
-
-228K
430.23%
-421K
84.65%
-15.49M
3,579.33%
14.88M
196.08%
-21.91M
247.18%
-4.08M
81.36%
6.30M
254.34%
-12.55M
299.29%
-167.13M
1,231.17%
135.05M
180.81%
debt repayment
-833K
-
-3.33M
300.12%
-3.33M
0%
-2.85M
14.55%
common stock issued
61.74M
-
11.99M
80.57%
8.04M
33.00%
47.14M
486.60%
25.57M
45.76%
40.83M
59.70%
104.26M
155.36%
144.64M
38.73%
88.40M
38.88%
common stock repurchased
dividends paid
-24.44M
-
other financing activites
41.45M
-
4.83M
88.34%
17.41M
260.26%
503K
97.11%
23K
95.43%
4K
82.61%
54K
1,250%
31K
42.59%
24.46M
78,803.23%
84K
99.66%
net cash used provided by financing activities
41.45M
-
4.83M
88.34%
78.33M
1,520.31%
9.16M
88.30%
4.73M
48.43%
44.30M
837.26%
25.62M
42.16%
40.86M
59.48%
104.28M
155.22%
144.72M
38.78%
88.40M
38.92%
effect of forex changes on cash
net change in cash
25.04M
-
-15.81M
163.12%
48.11M
404.39%
-39.18M
181.44%
-7.23M
81.56%
-1.07M
85.13%
-5.03M
368%
14.68M
391.69%
61.58M
319.61%
-65.94M
207.09%
155.00M
335.07%
cash at beginning of period
5.43M
-
30.47M
460.80%
14.67M
51.87%
62.78M
328.01%
23.60M
62.41%
16.48M
30.15%
15.41M
6.52%
10.38M
32.65%
25.05M
141.43%
86.63M
245.81%
20.69M
76.12%
cash at end of period
30.47M
-
14.67M
51.87%
62.78M
328.01%
23.60M
62.41%
16.37M
30.63%
15.41M
5.88%
10.38M
32.65%
25.05M
141.43%
86.63M
245.81%
20.69M
76.12%
175.69M
749.25%
operating cash flow
-16.37M
-
-20.41M
24.72%
-29.79M
45.96%
-32.86M
10.29%
-26.84M
18.33%
-23.46M
12.56%
-26.57M
13.23%
-32.48M
22.27%
-30.15M
7.18%
-43.53M
44.38%
-68.44M
57.23%
capital expenditure
-43K
-
-228K
430.23%
-421K
84.65%
-459K
9.03%
-57K
87.58%
18K
131.58%
-12K
166.67%
-33K
175%
-21K
36.36%
-91K
333.33%
-25K
72.53%
free cash flow
-16.41M
-
-20.64M
25.78%
-30.21M
46.39%
-33.32M
10.27%
-26.89M
19.28%
-23.45M
12.81%
-26.58M
13.37%
-32.52M
22.34%
-30.17M
7.21%
-43.62M
44.58%
-68.47M
56.95%

All numbers in USD (except ratios and percentages)